查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
睡眠软体市场按类型、产品、功能、适应症、部署模型、最终用户和地区划分 - 预测至 2030 年
市场调查报告书
商品编码
1648940

睡眠软体市场按类型、产品、功能、适应症、部署模型、最终用户和地区划分 - 预测至 2030 年

Sleep Software Market by Function, Indication, Offering (Platforms, Apps ), End-user, Deployment, Type, & Region - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 301 Pages | 订单完成后即时交付

价格

全球睡眠软体市场规模预计将从 2024 年的 8.789 亿美元成长到 2030 年的 15.692 亿美元，预测期内的复合年增长率为 10.1%。

随着个人和医疗保健系统更加重视主动的健康方法而不是被动的治疗，睡眠软体市场的成长正受到预防性保健转变的推动。睡眠软体可以在这一转变中发挥重要作用，它可以帮助使用者追踪自己的睡眠情况，及早发现睡眠问题，并养成有利于长期健康的习惯。随着人们越来越意识到睡眠品质与肥胖、心臟病和精神疾病等慢性疾病之间的联繫，消费者开始采用一些工具来帮助他们在问题变得严重之前解决潜在问题。

研究范围
调查年份 2022-2029
基准年 2023
预测期 2024-2029
考虑单位 金额（美元）
部分 按类型、按产品、按功能、按适应症、按部署模型、按最终用户、按地区
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东和非洲

根据产品范围，睡眠软体市场分为平台和应用程式。由于人们对睡眠健康认识的提高、睡眠障碍数量的增加以及技术的进步，预计行动应用程式领域将在预测期内以最快的速度增长，从而推动睡眠软体市场中基于行动的应用程式的激增。 Sleep Cycle、Calm 和 Headspace 等睡眠应用程式提供追踪、放鬆和与穿戴式装置整合等功能。紧张的生活方式和健康趋势进一步推动了需求，例如儿童专用的 Moshi 和治疗失眠的 CBT-I Coach 等产品。这些应用程式现在已被广泛使用，其实惠的定价模式和疫情主导的对心理健康的关注使它们对于改善睡眠管理至关重要。

根据部署模型，睡眠软体市场分为内部部署模型和云端基础模式。 2023年，云端基础部署模式占据睡眠软体市场的大部分份额。原因是扩充性、成本效益和可访问性。云端解决方案为用户提供跨装置的即时资料同步，同时易于扩展且无需庞大的基础架构成本。云端平台提供强大的资料安全性和无缝更新，允许持续存取最新的功能升级。其与其他健康平台的整合能力和全球影响力将进一步增强其在市场占有率方面的优势。

睡眠软体市场分为北美、欧洲、亚太、拉丁美洲和中东及非洲。亚太地区睡眠软体市场的发展源于人们越来越意识到睡眠在健康和生产力方面的重要作用，从而导致消费者对解决失眠和睡眠呼吸中止症等问题的兴趣日益浓厚。印度、中国和印尼等主要市场的中产阶级不断壮大和可支配收入不断增加，正在鼓励消费者将注意力转向健康并投资于以健康为中心的技术，从而推动对包括与应用程式和可穿戴设备整合的创新睡眠解决方案的需求。

本报告研究了全球睡眠软体市场，并对市场格局进行了详细分析，包括关键细分市场、应用和最终用户细分市场，以及关键地区和区域。

目录

第 1 章 简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

第五章 市场概况

  • 介绍
  • 市场动态
  • 影响客户业务的趋势/干扰
  • 产业趋势
  • 生态系分析
  • 供应链分析
  • 技术分析
  • 监管分析
  • 定价分析
  • 波特五力分析
  • 专利分析
  • 主要相关人员和采购标准
  • 最终用户分析
  • 2025-2026 年重要会议与活动
  • 案例研究分析
  • 投资金筹措场景
  • 经营模式分析
  • 人工智慧/生成式人工智慧将如何影响睡眠软体市场

第六章 睡眠软体市场（依类型）

  • 介绍
  • 整合软体
  • 独立软体

7. 睡眠软体市场（依产品分类）

  • 介绍
  • 平台
  • 应用

第 8 章 睡眠软体市场（按功能）

  • 介绍
  • 睡眠追踪
  • 改善睡眠
  • 睡眠追踪
  • 治疗睡眠障碍

第 9 章睡眠软体市场（按适应症）

  • 介绍
  • 失眠
  • 睡眠呼吸中止症
  • 整体睡眠改善
  • 其他的

第 10 章 睡眠软体市场（依部署模式）

  • 介绍
  • 本地部署模型
  • 云端基础的模型

第 11 章 睡眠软体市场（依最终用户）

  • 介绍
  • 个人用户
  • 医疗机构
  • 其他的

第 12 章 睡眠软体市场（按地区）

  • 介绍
  • 北美洲
    • 北美宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲宏观经济展望
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 亚太宏观经济展望
    • 中国
    • 印度
    • 日本
    • 其他的
  • 拉丁美洲
    • 拉丁美洲宏观经济展望
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 中东和非洲宏观经济展望
    • 海湾合作委员会国家
    • 其他的

第十三章 竞争格局

  • 介绍
  • 主要参与企业的策略/优势
  • 2019 至 2023 年收益分析
  • 2023 年市场占有率分析
  • 公司估值矩阵：主要参与企业，2023 年
  • 公司估值矩阵：Start-Ups/中小企业，2023 年
  • 估值及财务指标
  • 品牌/软体比较
  • 竞争场景

第十四章 公司简介

  • 主要参与企业
    • CALM
    • HEADSPACE INC.
    • RESMED
    • KONINKLIJKE PHILIPS NV
    • INSPIRE MEDICAL SYSTEMS, INC.
    • CADWELL INDUSTRIES INC.
    • COMPUMEDICS LIMITED
    • NEUROVIRTUAL
    • NIHON KOHDEN CORPORATION
    • NOX MEDICAL
    • NATUS MEDICAL INCORPORATED
    • RXNT
    • CLEVELAND MEDICAL DEVICES INC.
    • SOMNOMEDICS AG
    • CIDELEC
    • SLEEP CYCLE
    • LOWENSTEIN MEDICAL SE & CO. KG
    • CAMNTECH LTD.
    • FISHER & PAYKEL HEALTHCARE LIMITED
    • BIOSERENITY
    • VYAIRE MEDICAL, INC.
  • 其他参与企业
    • HONEYNAPS
    • SLEEPIMAGE
    • SLEEP RESET
    • BIGHEALTH
    • BODYMATTER, INC.
    • NEYBOX DIGITAL LTD.
    • CONSUMER SLEEP SOLUTIONS LLC

第十五章 附录

Product Code: HIT 9280

The global Sleep Software market is projected to reach USD 1,569.2 Million by 2030 from USD 878.9 million in 2024, at a CAGR of 10.1% during the forecast period. The growth in the sleep software market is driven by the shift towards preventive health since individuals and health systems are putting more emphasis on proactive wellness approaches rather than reacting to treatments. Sleep software can play a major role in such a shift by allowing users to track their sleep, spot early sleep issues, and develop healthier habits for long-term wellness. As awareness grows about the link between sleep quality and chronic conditions such as obesity, heart disease, and mental health disorders, consumers are increasingly adopting tools that help address potential issues before they become serious.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD)
SegmentsType, Offering, Function, Indication, Deployment Model, End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa

"The mobile applications segment is expected to register the fastest growth during the forecast period, by offering"

The Sleep Software market, by offering, is segmented into platforms and applications. The mobile applications segment is expected to grow the fastest during the forecast period due to the rapid growth of mobile-based applications in the sleep software market, which is driven by rising awareness of sleep health, increasing sleep disorders, and advancements in technology. Sleep apps such as Sleep Cycle, Calm, and Headspace offer features such as tracking, relaxation, and integration with wearables. Demand is further increased by stressful lives and health trends, with products such as Moshi for kids and CBT-I Coach for sleeplessness. These apps are now widely available and crucial for improved sleep management due to their affordable models and pandemic-driven mental health focus.

"Cloud-based segment dominated the sleep software market, by deployment model."

By deployment model, the Sleep Software market is divided into on-premise models and cloud-based models. In 2023, cloud-based models, by deployment model, held a large share of the Sleep Software market. Owing to its scalability, cost efficiency, and accessibility. Cloud solutions enable easy expansion without significant infrastructure costs while providing users with real-time data synchronization across devices. The cloud platforms offer robust data security and seamless updates that continue to allow access to the latest feature upgrades. Integration capabilities with other health platforms and global reach provide an added strength in terms of dominance in the market share.

"Asia Pacific is expected to register the fastest market growth during the forecast period."

The Sleep Software market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The sleep software market in the Asia Pacific region is being driven by growing awareness of sleep's critical role in health and productivity, with rising consumer focus on addressing issues like insomnia and sleep apnea, exacerbated by urbanization and high-stress lifestyles. The growing middle class and increasing disposable incomes in key markets such as India, China, and Indonesia fuel demand for innovative sleep solutions, including apps and wearable integrations, as consumers focus on wellness and invest in health-focused technologies.

The break-down of primary participants is as mentioned below:

  • By Company Type - Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
  • By Designation - Directors: 30%, Manager: 34%, and Others: 36%
  • By Region - North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3% and Middle East & Africa: 2%

List of Companies Profiled in the Report

1. Koninklijke Philips N.V. (Netherlands)

2. Cadwell Industries Inc. (US)

3. COMPUMEDICS LIMITED (Australia)

4. Neurovirtual. (US)

5. NIHON KOHDEN CORPORATION (Japan)

6. Nox Medical (Iceland)

7. Natus Medical Incorporated (ARCHIMED) (US)

8. RXNT (US)

9. Resmed (US)

10. Cleveland Medical Devices Inc. (US)

11. SOMNOmedics AG (Germany)

12. CIDELEC (France)

13. Calm (US)

14. Sleep Cycle (Sweden)

15. Headspace Inc. (US)

16. Lowenstein Medical SE & Co. KG (Germany)

17. CamNtech Ltd (United Kingdom)

18. Fisher & Paykel Healthcare Limited. (New Zealand)

19. BioSerenity (France)

20. VYAIRE MEDICAL INC (US)

21. Inspire Medical Systems, Inc. (US)

22. HoneyNaps (South Korea)

23. Sleep Reset (US)

24. SleepImage. (US)

25. BigHealth (US)

26. Bodymatter, Inc. (US)

27. Neybox Digital Ltd. (US)

28. Consumer Sleep Solutions LLC. (US)

Research Coverage:

The report analyzes the sleep software market and aims to estimate the market size and future growth potential of various market segments based on type, offering, function, indication, deployment model, end user, and region. The report also analyses factors (such as drivers, opportunities, and challenges) affecting market growth. It evaluates the opportunities and challenges for stakeholders in the market. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total sleep software market. The report forecasts the revenue of the market segments with respect to five major regions. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

  • Analysis of key drivers (growing incidence of sleep disorders, increasing adoption of telehealth and mhealth, increasing emphasis on corporate wellness programs, growing awareness regarding sleep apnea and wellness improvement, favorable reimbursement and financial aid for sleep apnea devices and therapies), restraints (use of alternative therapies and medications for sleep disorders, data security and privacy concerns, resistance from tradition healthcare providers), opportunities (adoption of advanced technologies, integration with wearable devices, personalized sleep solutions, mental health and wellness integration), challenges (lack of clinical validation for many solutions, regulatory compliance complexities, growing concerns about data privacy and security.) are factors contributing the growth of the sleep software market.
  • Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the sleep software market.
  • Market Development: Comprehensive information on the lucrative emerging markets, type, offering, function, indications, deployment model, end user, and region.
  • Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, and investments in the sleep software market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global sleep software market such as Koninklijke Philips N.V. (Netherlands), Resmed (US), Calm (US), Headspace Inc. (US), Inspire Medical Systems, Inc. (US).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKET SEGMENTATION
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key industry insights
  • 2.2 MARKET ESTIMATION METHODOLOGY
  • 2.3 MARKET SIZE ESTIMATION
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5 RESEARCH ASSUMPTIONS
    • 2.5.1 MARKET SIZING ASSUMPTIONS
    • 2.5.2 OVERALL STUDY ASSUMPTIONS
  • 2.6 RISK ASSESSMENT
  • 2.7 RESEARCH LIMITATIONS
    • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.7.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 SLEEP SOFTWARE MARKET OVERVIEW
  • 4.2 NORTH AMERICA: SLEEP SOFTWARE MARKET, BY END USER & REGION
  • 4.3 SLEEP SOFTWARE MARKET: GEOGRAPHIC MIX
  • 4.4 SLEEP SOFTWARE MARKET: DEVELOPED VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Expansion of telehealth and remote patient monitoring
      • 5.2.1.2 Vast population of undiagnosed sleep apnea patients
      • 5.2.1.3 Growing awareness regarding sleep apnea and wellness improvement
      • 5.2.1.4 Favorable reimbursement and financial aid for sleep apnea devices and therapies
      • 5.2.1.5 Increasing emphasis on corporate wellness programs
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Data privacy and security concerns
      • 5.2.2.2 Use of alternative therapies and medications for sleep disorders
      • 5.2.2.3 Resistance from traditional healthcare providers
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Development of mHealth tools
      • 5.2.3.2 Rising potential of AI & ML in sleep medicine
      • 5.2.3.3 Rising demand for smart wearables
      • 5.2.3.4 Increasing focus on mental health and wellbeing
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Lack of clinical validation of sleep apps
      • 5.2.4.2 Strategic challenges in monetizing sleep apps
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.4 INDUSTRY TRENDS
    • 5.4.1 VALUE-BASED CARE MODELS
    • 5.4.2 CLOUD-BASED SOLUTIONS
    • 5.4.3 IOT AND WEARABLES
  • 5.5 ECOSYSTEM ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 TECHNOLOGY ANALYSIS
    • 5.7.1 KEY TECHNOLOGIES
      • 5.7.1.1 Artificial intelligence & machine learning
      • 5.7.1.2 Internet of things (IoT)
      • 5.7.1.3 Mobile applications
      • 5.7.1.4 Biosensors and wearable technology
      • 5.7.1.5 Gamification technology
      • 5.7.1.6 Voice assistants
    • 5.7.2 COMPLEMENTARY TECHNOLOGIES
      • 5.7.2.1 Smart home automation
      • 5.7.2.2 Telemedicine platforms
      • 5.7.2.3 Data analysis and visualization tools
      • 5.7.2.4 EHR integration
      • 5.7.2.5 Cloud computing
    • 5.7.3 ADJACENT TECHNOLOGIES
      • 5.7.3.1 Fitness trackers
      • 5.7.3.2 Respiratory monitoring devices
      • 5.7.3.3 Augmented reality (AR) & virtual reality (VR)
  • 5.8 REGULATORY ANALYSIS
    • 5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.8.2 REGULATORY SCENARIO
      • 5.8.2.1 North America
      • 5.8.2.2 Europe
      • 5.8.2.3 Asia Pacific
      • 5.8.2.4 Middle East & Africa
      • 5.8.2.5 Latin America
  • 5.9 PRICING ANALYSIS
    • 5.9.1 AVERAGE SELLING PRICE OF SLEEP APPS, BY KEY PLAYER (2023)
    • 5.9.2 AVERAGE SELLING PRICE OF SLEEP APPS, BY REGION (2023)
  • 5.10 PORTER'S FIVE FORCES ANALYSIS
    • 5.10.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.10.2 BARGAINING POWER OF BUYERS
    • 5.10.3 THREAT OF SUBSTITUTES
    • 5.10.4 THREAT OF NEW ENTRANTS
    • 5.10.5 BARGAINING POWER OF SUPPLIERS
  • 5.11 PATENT ANALYSIS
    • 5.11.1 PATENT PUBLICATION TRENDS
    • 5.11.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR SLEEP SOFTWARE
    • 5.11.3 MAJOR PATENTS IN SLEEP SOFTWARE MARKET
  • 5.12 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.12.2 KEY BUYING CRITERIA
  • 5.13 END-USER ANALYSIS
    • 5.13.1 UNMET NEEDS
    • 5.13.2 END-USER EXPECTATIONS
  • 5.14 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.15 CASE STUDY ANALYSIS
    • 5.15.1 CASE STUDY 1: TRANSFORMING SLEEP STUDY AT ST. LUKE'S SLEEP MEDICINE INSTITUTE
    • 5.15.2 CASE STUDY 2: GRANGER MEDICAL CLINIC'S PATH TO EFFICIENT HEALTHCARE OPERATIONS
  • 5.16 INVESTMENT & FUNDING SCENARIO
  • 5.17 BUSINESS MODEL ANALYSIS
  • 5.18 IMPACT OF AI/GEN AI ON SLEEP SOFTWARE MARKET
    • 5.18.1 KEY USE CASES
    • 5.18.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
      • 5.18.2.1 Case study 1: Leveraging AI to drive improved patient adherence and operational efficiency at Aeroflow Sleep
      • 5.18.2.2 Case study 2: Optimizing sleep lab workflow and enhancing patient care with EnsoSleep AI at Northwell Health
    • 5.18.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
      • 5.18.3.1 Remote patient monitoring market
      • 5.18.3.2 Digital health market
      • 5.18.3.3 Telehealth and telemedicine market
      • 5.18.3.4 mHealth market
    • 5.18.4 USER READINESS AND IMPACT ASSESSMENT
      • 5.18.4.1 User readiness
        • 5.18.4.1.1 User A: Individual users
        • 5.18.4.1.2 User B: Healthcare providers
      • 5.18.4.2 Impact assessment
        • 5.18.4.2.1 User A: Individual users
        • 5.18.4.2.2 User B: Healthcare providers

6 SLEEP SOFTWARE MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 INTEGRATED SOFTWARE
    • 6.2.1 NEED FOR INTEGRATED SOFTWARE WITHIN BROADER HEALTH AND WELLNESS ECOSYSTEMS TO BOLSTER GROWTH
  • 6.3 STANDALONE SOFTWARE
    • 6.3.1 RISING TREND TOWARD MOBILE HEALTH APPLICATIONS TO INTENSIFY GROWTH

7 SLEEP SOFTWARE MARKET, BY OFFERING

  • 7.1 INTRODUCTION
  • 7.2 PLATFORMS
    • 7.2.1 GROWING ADOPTION OF CONNECTED HEALTH TECHNOLOGIES TO BOOST MARKET
  • 7.3 APPLICATIONS
    • 7.3.1 MOBILE APPLICATIONS
      • 7.3.1.1 Increasing penetration of smartphones and consumer demand for on-the-go health monitoring tools to aid growth
    • 7.3.2 DESKTOP APPLICATIONS
      • 7.3.2.1 Need for advanced solutions to address sleep issues and improve sleep quality to expedite growth

8 SLEEP SOFTWARE MARKET, BY FUNCTION

  • 8.1 INTRODUCTION
  • 8.2 SLEEP TRACKING
    • 8.2.1 RISING HEALTH AWARENESS ABOUT IMPORTANCE OF SLEEP TO FACILITATE GROWTH
  • 8.3 SLEEP IMPROVEMENT
    • 8.3.1 INCREASING PREFERENCE FOR NON-INVASIVE SOLUTIONS FOR SLEEP IMPROVEMENT TO FAVOR GROWTH
  • 8.4 SLEEP ANALYSIS
    • 8.4.1 GROWING INTEGRATION OF SLEEP ANALYSIS TOOLS INTO WEARABLES TO FUEL MARKET
  • 8.5 SLEEP DISORDER MANAGEMENT
    • 8.5.1 INCREASING RESEARCH ON SLEEP DISORDER DIAGNOSTICS TO SUPPORT GROWTH

9 SLEEP SOFTWARE MARKET, BY INDICATION

  • 9.1 INTRODUCTION
  • 9.2 INSOMNIA
    • 9.2.1 RISING MENTAL HEALTH ISSUES AND DEMAND FOR NON-PHARMACOLOGICAL TREATMENTS TO AID GROWTH
  • 9.3 SLEEP APNEA
    • 9.3.1 GROWING PATIENT SHIFT TO DIGITAL SOLUTIONS TO BOOST MARKET
  • 9.4 GENERAL SLEEP IMPROVEMENT
    • 9.4.1 RISE IN HEALTH CONSCIOUSNESS AMONG CONSUMERS TO AUGMENT GROWTH
  • 9.5 OTHER INDICATIONS

10 SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL

  • 10.1 INTRODUCTION
  • 10.2 ON-PREMISE MODELS
    • 10.2.1 NEED FOR ENHANCED DATA CONTROL, SECURITY, AND COMPLIANCE TO PROMOTE GROWTH
  • 10.3 CLOUD-BASED MODELS
    • 10.3.1 GROWING ADOPTION OF REMOTE PATIENT MONITORING SYSTEMS TO DRIVE MARKET

11 SLEEP SOFTWARE MARKET, BY END USER

  • 11.1 INTRODUCTION
  • 11.2 INDIVIDUAL USERS
    • 11.2.1 GROWING AWARENESS OF SLEEP HEALTH AND ADOPTION OF WEARABLE TRACKERS TO PROPEL MARKET
  • 11.3 HEALTHCARE PROVIDERS
    • 11.3.1 RISING TECHNOLOGICAL ADVANCEMENTS IN SLEEP SOFTWARE TO DRIVE MARKET
  • 11.4 OTHER END USERS

12 SLEEP SOFTWARE MARKET, BY REGION

  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    • 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 12.2.2 US
      • 12.2.2.1 Increasing investments due to reduced workplace productivity and decreased quality of life to drive market
    • 12.2.3 CANADA
      • 12.2.3.1 Government investments and increasing awareness to drive market
  • 12.3 EUROPE
    • 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 12.3.2 GERMANY
      • 12.3.2.1 Growing need for effective diagnostic and treatment solutions to drive market
    • 12.3.3 UK
      • 12.3.3.1 Rising interest in sleep management apps to favor market
    • 12.3.4 FRANCE
      • 12.3.4.1 Rising awareness and supportive government initiatives to fuel market growth
    • 12.3.5 ITALY
      • 12.3.5.1 Growing insomnia prevalence in Italy to propel market
    • 12.3.6 SPAIN
      • 12.3.6.1 Increasing incidence of sleep problems in younger populations to drive demand
    • 12.3.7 REST OF EUROPE
  • 12.4 ASIA PACIFIC
    • 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 12.4.2 CHINA
      • 12.4.2.1 Rising sleep disorder prevalence to drive market
    • 12.4.3 INDIA
      • 12.4.3.1 Collaborative efforts with other countries to support market growth
    • 12.4.4 JAPAN
      • 12.4.4.1 Need for digital solutions and government initiatives to drive market
    • 12.4.5 REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    • 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 12.5.2 BRAZIL
      • 12.5.2.1 Rising cases of sleep disorders among older adults to drive market
    • 12.5.3 MEXICO
      • 12.5.3.1 Socioeconomic factors and environmental stressors to support market growth
    • 12.5.4 REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST & AFRICA
    • 12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 12.6.2 GCC COUNTRIES
      • 12.6.2.1 Rising obesity rate to drive demand for sleep disorder treatment solutions in GCC countries
    • 12.6.3 REST OF MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE

  • 13.1 INTRODUCTION
  • 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SLEEP SOFTWARE MARKET
  • 13.3 REVENUE ANALYSIS, 2019-2023
  • 13.4 MARKET SHARE ANALYSIS, 2023
  • 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 13.5.1 STARS
    • 13.5.2 EMERGING LEADERS
    • 13.5.3 PERVASIVE PLAYERS
    • 13.5.4 PARTICIPANTS
    • 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 13.5.5.1 Company footprint
      • 13.5.5.2 Region footprint
      • 13.5.5.3 Type footprint
      • 13.5.5.4 Offering footprint
      • 13.5.5.5 Function footprint
      • 13.5.5.6 Indication footprint
      • 13.5.5.7 Deployment footprint
      • 13.5.5.8 End-user footprint
  • 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 13.6.1 PROGRESSIVE COMPANIES
    • 13.6.2 RESPONSIVE COMPANIES
    • 13.6.3 DYNAMIC COMPANIES
    • 13.6.4 STARTING BLOCKS
    • 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
      • 13.6.5.1 Detailed list of key startups/SMEs
      • 13.6.5.2 Competitive benchmarking of key startups/SMEs
  • 13.7 COMPANY VALUATION & FINANCIAL METRICS
  • 13.8 BRAND/SOFTWARE COMPARISON
  • 13.9 COMPETITIVE SCENARIO
    • 13.9.1 PRODUCT LAUNCHES & ENHANCEMENTS
    • 13.9.2 DEALS
    • 13.9.3 EXPANSIONS
    • 13.9.4 OTHER DEVELOPMENTS

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
    • 14.1.1 CALM
      • 14.1.1.1 Business overview
      • 14.1.1.2 Solutions offered
      • 14.1.1.3 Recent developments
        • 14.1.1.3.1 Deals
      • 14.1.1.4 MnM view
        • 14.1.1.4.1 Right to win
        • 14.1.1.4.2 Strategic choices
        • 14.1.1.4.3 Weaknesses & competitive threats
    • 14.1.2 HEADSPACE INC.
      • 14.1.2.1 Business overview
      • 14.1.2.2 Solutions offered
      • 14.1.2.3 Recent developments
        • 14.1.2.3.1 Product launches
        • 14.1.2.3.2 Deals
        • 14.1.2.3.3 Other developments
      • 14.1.2.4 MnM view
        • 14.1.2.4.1 Right to win
        • 14.1.2.4.2 Strategic choices
        • 14.1.2.4.3 Weaknesses & competitive threats
    • 14.1.3 RESMED
      • 14.1.3.1 Business overview
      • 14.1.3.2 Solutions offered
      • 14.1.3.3 Recent developments
        • 14.1.3.3.1 Product enhancements
        • 14.1.3.3.2 Deals
        • 14.1.3.3.3 Expansions
      • 14.1.3.4 MnM view
        • 14.1.3.4.1 Right to win
        • 14.1.3.4.2 Strategic choices
        • 14.1.3.4.3 Weaknesses & competitive threats
    • 14.1.4 KONINKLIJKE PHILIPS N.V.
      • 14.1.4.1 Business overview
      • 14.1.4.2 Solutions offered
      • 14.1.4.3 MnM view
        • 14.1.4.3.1 Right to win
        • 14.1.4.3.2 Strategic choices
        • 14.1.4.3.3 Weaknesses & competitive threats
    • 14.1.5 INSPIRE MEDICAL SYSTEMS, INC.
      • 14.1.5.1 Business overview
      • 14.1.5.2 Solutions offered
      • 14.1.5.3 MnM view
        • 14.1.5.3.1 Right to win
        • 14.1.5.3.2 Strategic choices
        • 14.1.5.3.3 Weaknesses & competitive threats
    • 14.1.6 CADWELL INDUSTRIES INC.
      • 14.1.6.1 Business overview
      • 14.1.6.2 Solutions offered
      • 14.1.6.3 Recent developments
        • 14.1.6.3.1 Deals
    • 14.1.7 COMPUMEDICS LIMITED
      • 14.1.7.1 Business overview
      • 14.1.7.2 Solutions offered
    • 14.1.8 NEUROVIRTUAL
      • 14.1.8.1 Business overview
      • 14.1.8.2 Solutions offered
      • 14.1.8.3 Recent developments
        • 14.1.8.3.1 Expansions
    • 14.1.9 NIHON KOHDEN CORPORATION
      • 14.1.9.1 Business overview
      • 14.1.9.2 Solutions offered
      • 14.1.9.3 Recent developments
        • 14.1.9.3.1 Deals
        • 14.1.9.3.2 Expansions
    • 14.1.10 NOX MEDICAL
      • 14.1.10.1 Business overview
      • 14.1.10.2 Solutions offered
      • 14.1.10.3 Recent developments
        • 14.1.10.3.1 Product launches & enhancements
    • 14.1.11 NATUS MEDICAL INCORPORATED
      • 14.1.11.1 Business overview
      • 14.1.11.2 Solutions offered
      • 14.1.11.3 Recent developments
        • 14.1.11.3.1 Deals
    • 14.1.12 RXNT
      • 14.1.12.1 Business overview
      • 14.1.12.2 Solutions offered
      • 14.1.12.3 Recent developments
        • 14.1.12.3.1 Product launches
    • 14.1.13 CLEVELAND MEDICAL DEVICES INC.
      • 14.1.13.1 Business overview
      • 14.1.13.2 Solutions offered
      • 14.1.13.3 Recent developments
        • 14.1.13.3.1 Product enhancements
    • 14.1.14 SOMNOMEDICS AG
      • 14.1.14.1 Business overview
      • 14.1.14.2 Solutions offered
      • 14.1.14.3 Recent developments
        • 14.1.14.3.1 Deals
    • 14.1.15 CIDELEC
      • 14.1.15.1 Business overview
      • 14.1.15.2 Solutions offered
    • 14.1.16 SLEEP CYCLE
      • 14.1.16.1 Business overview
      • 14.1.16.2 Solutions offered
      • 14.1.16.3 Recent developments
        • 14.1.16.3.1 Product launches
        • 14.1.16.3.2 Deals
    • 14.1.17 LOWENSTEIN MEDICAL SE & CO. KG
      • 14.1.17.1 Business overview
      • 14.1.17.2 Solutions offered
    • 14.1.18 CAMNTECH LTD.
      • 14.1.18.1 Business overview
      • 14.1.18.2 Solutions offered
      • 14.1.18.3 Recent developments
        • 14.1.18.3.1 Product launches
    • 14.1.19 FISHER & PAYKEL HEALTHCARE LIMITED
      • 14.1.19.1 Business overview
      • 14.1.19.2 Solutions offered
      • 14.1.19.3 Recent developments
        • 14.1.19.3.1 Product launches
        • 14.1.19.3.2 Expansions
    • 14.1.20 BIOSERENITY
      • 14.1.20.1 Business overview
      • 14.1.20.2 Solutions offered
      • 14.1.20.3 Recent developments
        • 14.1.20.3.1 Other developments
    • 14.1.21 VYAIRE MEDICAL, INC.
      • 14.1.21.1 Business overview
      • 14.1.21.2 Solutions offered
  • 14.2 OTHER PLAYERS
    • 14.2.1 HONEYNAPS
    • 14.2.2 SLEEPIMAGE
    • 14.2.3 SLEEP RESET
    • 14.2.4 BIGHEALTH
    • 14.2.5 BODYMATTER, INC.
    • 14.2.6 NEYBOX DIGITAL LTD.
    • 14.2.7 CONSUMER SLEEP SOLUTIONS LLC

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • TABLE 2 SLEEP SOFTWARE MARKET: FACTOR ANALYSIS
  • TABLE 3 SLEEP SOFTWARE MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 4 SLEEP SOFTWARE MARKET: IMPACT ANALYSIS
  • TABLE 5 ESTIMATED PREVALENCE OF SLEEP APNEA, 2022-2024
  • TABLE 6 INITIATIVES TO PROMOTE AWARENESS ABOUT EFFECTS OF UNTREATED SLEEP APNEA
  • TABLE 7 TOP 30 HEALTHCARE DATA BREACHES IN US, 2011-2024
  • TABLE 8 SLEEP SOFTWARE MARKET: ROLE IN ECOSYSTEM
  • TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 REGULATORY SCENARIO OF NORTH AMERICA
  • TABLE 15 REGULATORY SCENARIO OF EUROPE
  • TABLE 16 REGULATORY SCENARIO OF ASIA PACIFIC
  • TABLE 17 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA
  • TABLE 18 REGULATORY SCENARIO OF LATIN AMERICA
  • TABLE 19 AVERAGE SELLING PRICE OF SLEEP APPS, BY REGION (2023)
  • TABLE 20 SLEEP SOFTWARE MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 21 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR SLEEP SOFTWARE
  • TABLE 22 SLEEP SOFTWARE MARKET: LIST OF PATENTS/PATENT APPLICATIONS
  • TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP TWO END USERS (%)
  • TABLE 24 KEY BUYING CRITERIA FOR TOP END USERS
  • TABLE 25 UNMET NEEDS IN SLEEP SOFTWARE MARKET
  • TABLE 26 END-USER EXPECTATIONS IN SLEEP SOFTWARE MARKET
  • TABLE 27 SLEEP SOFTWARE MARKET: KEY CONFERENCES & EVENTS, JANUARY 2025- DECEMBER 2026
  • TABLE 28 SLEEP SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 29 SLEEP SOFTWARE MARKET FOR INTEGRATED SOFTWARE, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 30 SLEEP SOFTWARE MARKET FOR STANDALONE SOFTWARE, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 31 SLEEP SOFTWARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
  • TABLE 32 SLEEP SOFTWARE MARKET FOR PLATFORMS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 33 SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 34 SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 35 SLEEP SOFTWARE MARKET FOR MOBILE APPLICATIONS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 36 SLEEP SOFTWARE MARKET FOR DESKTOP APPLICATIONS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 37 SLEEP SOFTWARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 38 SLEEP SOFTWARE MARKET FOR SLEEP TRACKING, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 39 SLEEP SOFTWARE MARKET FOR SLEEP IMPROVEMENT, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 40 SLEEP SOFTWARE MARKET FOR SLEEP ANALYSIS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 41 SLEEP SOFTWARE MARKET FOR SLEEP DISORDER MANAGEMENT, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 42 SLEEP SOFTWARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 43 SLEEP SOFTWARE MARKET FOR INSOMNIA, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 44 SLEEP SOFTWARE MARKET FOR SLEEP APNEA, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 45 SLEEP SOFTWARE MARKET FOR GENERAL SLEEP IMPROVEMENT, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 46 SLEEP SOFTWARE MARKET FOR OTHER INDICATIONS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 47 SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
  • TABLE 48 SLEEP SOFTWARE MARKET FOR ON-PREMISE MODELS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 49 SLEEP SOFTWARE MARKET FOR CLOUD-BASED MODELS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 50 SLEEP SOFTWARE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 51 SLEEP SOFTWARE MARKET FOR INDIVIDUAL USERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 52 SLEEP SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 53 SLEEP SOFTWARE MARKET FOR OTHER END USERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 54 SLEEP SOFTWARE MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 55 NORTH AMERICA: SLEEP SOFTWARE MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 56 NORTH AMERICA: SLEEP SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 57 NORTH AMERICA: SLEEP SOFTWARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
  • TABLE 58 NORTH AMERICA: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 59 NORTH AMERICA: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 60 NORTH AMERICA: SLEEP SOFTWARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 61 NORTH AMERICA: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
  • TABLE 62 NORTH AMERICA: SLEEP SOFTWARE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 63 US: SLEEP SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 64 US: SLEEP SOFTWARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
  • TABLE 65 US: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 66 US: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 67 US: SLEEP SOFTWARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 68 US: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
  • TABLE 69 US: SLEEP SOFTWARE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 70 CANADA: SLEEP SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 71 CANADA: SLEEP SOFTWARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
  • TABLE 72 CANADA: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 73 CANADA: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 74 CANADA: SLEEP SOFTWARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 75 CANADA: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
  • TABLE 76 CANADA: SLEEP SOFTWARE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 77 EUROPE: SLEEP SOFTWARE MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 78 EUROPE: SLEEP SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 79 EUROPE: SLEEP SOFTWARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
  • TABLE 80 EUROPE: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 81 EUROPE: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 82 EUROPE: SLEEP SOFTWARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 83 EUROPE: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
  • TABLE 84 EUROPE: SLEEP SOFTWARE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 85 GERMANY: SLEEP SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 86 GERMANY: SLEEP SOFTWARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
  • TABLE 87 GERMANY: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 88 GERMANY: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 89 GERMANY: SLEEP SOFTWARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 90 GERMANY: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
  • TABLE 91 GERMANY: SLEEP SOFTWARE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 92 UK: SLEEP SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 93 UK: SLEEP SOFTWARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
  • TABLE 94 UK: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 95 UK: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 96 UK: SLEEP SOFTWARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 97 UK: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
  • TABLE 98 UK: SLEEP SOFTWARE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 99 FRANCE: SLEEP SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 100 FRANCE: SLEEP SOFTWARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
  • TABLE 101 FRANCE: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 102 FRANCE: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 103 FRANCE: SLEEP SOFTWARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 104 FRANCE: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
  • TABLE 105 FRANCE: SLEEP SOFTWARE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 106 ITALY: SLEEP SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 107 ITALY: SLEEP SOFTWARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
  • TABLE 108 ITALY: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 109 ITALY: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 110 ITALY: SLEEP SOFTWARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 111 ITALY: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
  • TABLE 112 ITALY: SLEEP SOFTWARE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 113 SPAIN: SLEEP SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 114 SPAIN: SLEEP SOFTWARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
  • TABLE 115 SPAIN: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 116 SPAIN: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 117 SPAIN: SLEEP SOFTWARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 118 SPAIN: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
  • TABLE 119 SPAIN: SLEEP SOFTWARE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 120 REST OF EUROPE: SLEEP SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 121 REST OF EUROPE: SLEEP SOFTWARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
  • TABLE 122 REST OF EUROPE: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 123 REST OF EUROPE: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 124 REST OF EUROPE: SLEEP SOFTWARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 125 REST OF EUROPE: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
  • TABLE 126 REST OF EUROPE: SLEEP SOFTWARE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 127 ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 128 ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 129 ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
  • TABLE 130 ASIA PACIFIC: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 131 ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 132 ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 133 ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
  • TABLE 134 ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 135 CHINA: SLEEP SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 136 CHINA: SLEEP SOFTWARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
  • TABLE 137 CHINA: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 138 CHINA: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 139 CHINA: SLEEP SOFTWARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 140 CHINA: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
  • TABLE 141 CHINA: SLEEP SOFTWARE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 142 INDIA: SLEEP SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 143 INDIA: SLEEP SOFTWARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
  • TABLE 144 INDIA: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 145 INDIA: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 146 INDIA: SLEEP SOFTWARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 147 INDIA: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
  • TABLE 148 INDIA: SLEEP SOFTWARE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 149 JAPAN: SLEEP SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 150 JAPAN: SLEEP SOFTWARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
  • TABLE 151 JAPAN: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 152 JAPAN: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 153 JAPAN: SLEEP SOFTWARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 154 JAPAN: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
  • TABLE 155 JAPAN: SLEEP SOFTWARE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 156 REST OF ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 157 REST OF ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
  • TABLE 158 REST OF ASIA PACIFIC: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 159 REST OF ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 160 REST OF ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 161 REST OF ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
  • TABLE 162 REST OF ASIA PACIFIC: SLEEP SOFTWARE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 163 LATIN AMERICA: SLEEP SOFTWARE MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 164 LATIN AMERICA: SLEEP SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 165 LATIN AMERICA: SLEEP SOFTWARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
  • TABLE 166 LATIN AMERICA: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 167 LATIN AMERICA: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 168 LATIN AMERICA: SLEEP SOFTWARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 169 LATIN AMERICA: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
  • TABLE 170 LATIN AMERICA: SLEEP SOFTWARE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 171 BRAZIL: SLEEP SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 172 BRAZIL: SLEEP SOFTWARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
  • TABLE 173 BRAZIL: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 174 BRAZIL: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 175 BRAZIL: SLEEP SOFTWARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 176 BRAZIL: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
  • TABLE 177 BRAZIL: SLEEP SOFTWARE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 178 MEXICO: SLEEP SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 179 MEXICO: SLEEP SOFTWARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
  • TABLE 180 MEXICO: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 181 MEXICO: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 182 MEXICO: SLEEP SOFTWARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 183 MEXICO: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
  • TABLE 184 MEXICO: SLEEP SOFTWARE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 185 REST OF LATIN AMERICA: SLEEP SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 186 REST OF LATIN AMERICA: SLEEP SOFTWARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
  • TABLE 187 REST OF LATIN AMERICA: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 188 REST OF LATIN AMERICA: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 189 REST OF LATIN AMERICA: SLEEP SOFTWARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 190 REST OF LATIN AMERICA: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
  • TABLE 191 REST OF LATIN AMERICA: SLEEP SOFTWARE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 192 MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 193 MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 194 MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
  • TABLE 195 MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 196 MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 197 MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 198 MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
  • TABLE 199 MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 200 GCC COUNTRIES: SLEEP SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 201 GCC COUNTRIES: SLEEP SOFTWARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
  • TABLE 202 GCC COUNTRIES: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 203 GCC COUNTRIES: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 204 GCC COUNTRIES: SLEEP SOFTWARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 205 GCC COUNTRIES: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
  • TABLE 206 GCC COUNTRIES: SLEEP SOFTWARE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 207 REST OF MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 208 REST OF MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY OFFERING, 2022-2030 (USD MILLION)
  • TABLE 209 REST OF MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET FOR APPLICATIONS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 210 REST OF MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 211 REST OF MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 212 REST OF MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2022-2030 (USD MILLION)
  • TABLE 213 REST OF MIDDLE EAST & AFRICA: SLEEP SOFTWARE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 214 SLEEP SOFTWARE MARKET: OVERVIEW OF STRATEGIES DEPLOYED KEY PLAYERS, JANUARY 2021-JANUARY 2025
  • TABLE 215 SLEEP SOFTWARE MARKET: DEGREE OF COMPETITION
  • TABLE 216 SLEEP SOFTWARE MARKET: REGION FOOTPRINT
  • TABLE 217 SLEEP SOFTWARE MARKET: TYPE FOOTPRINT
  • TABLE 218 SLEEP SOFTWARE MARKET: OFFERING FOOTPRINT
  • TABLE 219 SLEEP SOFTWARE MARKET: FUNCTION FOOTPRINT
  • TABLE 220 SLEEP SOFTWARE MARKET: INDICATION FOOTPRINT
  • TABLE 221 SLEEP SOFTWARE MARKET: DEPLOYMENT FOOTPRINT
  • TABLE 222 SLEEP SOFTWARE MARKET: END-USER FOOTPRINT
  • TABLE 223 SLEEP SOFTWARE MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 224 SLEEP SOFTWARE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY REGION
  • TABLE 225 SLEEP SOFTWARE MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 226 SLEEP SOFTWARE MARKET: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 227 SLEEP SOFTWARE MARKET: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 228 SLEEP SOFTWARE MARKET: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 229 CALM: COMPANY OVERVIEW
  • TABLE 230 CALM: SOLUTIONS OFFERED
  • TABLE 231 CALM: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 232 HEADSPACE INC.: COMPANY OVERVIEW
  • TABLE 233 HEADSPACE INC.: SOLUTIONS OFFERED
  • TABLE 234 HEADSPACE INC.: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 235 HEADSPACE INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 236 HEADSPACE INC.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 237 RESMED: COMPANY OVERVIEW
  • TABLE 238 RESMED: SOLUTIONS OFFERED
  • TABLE 239 RESMED: PRODUCT ENHANCEMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 240 RESMED: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 241 RESMED: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 242 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 243 KONINKLIJKE PHILIPS N.V.: SOLUTIONS OFFERED
  • TABLE 244 INSPIRE MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW
  • TABLE 245 INSPIRE MEDICAL SYSTEMS, INC.: SOLUTIONS OFFERED
  • TABLE 246 CADWELL INDUSTRIES INC.: COMPANY OVERVIEW
  • TABLE 247 CADWELL INDUSTRIES INC.: SOLUTIONS OFFERED
  • TABLE 248 CADWELL INDUSTRIES INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 249 COMPUMEDICS LIMITED: COMPANY OVERVIEW
  • TABLE 250 COMPUMEDICS LIMITED: SOLUTIONS OFFERED
  • TABLE 251 NEUROVIRTUAL: COMPANY OVERVIEW
  • TABLE 252 NEUROVIRTUAL: SOLUTIONS OFFERED
  • TABLE 253 NEUROVIRTUAL: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 254 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
  • TABLE 255 NIHON KOHDEN CORPORATION: SOLUTIONS OFFERED
  • TABLE 256 NIHON KOHDEN CORPORATION: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 257 NIHON KOHDEN CORPORATION: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 258 NOX MEDICAL: COMPANY OVERVIEW
  • TABLE 259 NOX MEDICAL: SOLUTIONS OFFERED
  • TABLE 260 NOX MEDICAL: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 261 NATUS MEDICAL INCORPORATED: COMPANY OVERVIEW
  • TABLE 262 NATUS MEDICAL INCORPORATED: SOLUTIONS OFFERED
  • TABLE 263 NATUS MEDICAL INCORPORATED: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 264 RXNT: COMPANY OVERVIEW
  • TABLE 265 RXNT: SOLUTIONS OFFERED
  • TABLE 266 RXNT: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 267 CLEVELAND MEDICAL DEVICES INC.: COMPANY OVERVIEW
  • TABLE 268 CLEVELAND MEDICAL DEVICES INC.: SOLUTIONS OFFERED
  • TABLE 269 CLEVELAND MEDICAL DEVICES INC.: PRODUCT ENHANCEMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 270 SOMNOMEDICS AG: COMPANY OVERVIEW
  • TABLE 271 SOMNOMEDICS AG: SOLUTIONS OFFERED
  • TABLE 272 SOMNOMEDICS AG: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 273 CIDELEC: COMPANY OVERVIEW
  • TABLE 274 CIDELEC: SOLUTIONS OFFERED
  • TABLE 275 SLEEP CYCLE: COMPANY OVERVIEW
  • TABLE 276 SLEEP CYCLE: SOLUTIONS OFFERED
  • TABLE 277 SLEEP CYCLE: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 278 SLEEP CYCLE: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 279 LOWENSTEIN MEDICAL SE & CO. KG: COMPANY OVERVIEW
  • TABLE 280 LOWENSTEIN MEDICAL SE & CO. KG: SOLUTIONS OFFERED
  • TABLE 281 CAMNTECH LTD.: COMPANY OVERVIEW
  • TABLE 282 CAMNTECH LTD.: SOLUTIONS OFFERED
  • TABLE 283 CAMNTECH LTD.: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 284 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY OVERVIEW
  • TABLE 285 FISHER & PAYKEL HEALTHCARE LIMITED: SOLUTIONS OFFERED
  • TABLE 286 FISHER & PAYKEL HEALTHCARE LIMITED: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 287 FISHER & PAYKEL HEALTHCARE LIMITED: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 288 BIOSERENITY: COMPANY OVERVIEW
  • TABLE 289 BIOSERENITY: SOLUTIONS OFFERED
  • TABLE 290 BIOSERENITY: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 291 VYAIRE MEDICAL, INC.: COMPANY OVERVIEW
  • TABLE 292 VYAIRE MEDICAL, INC.: SOLUTIONS OFFERED
  • TABLE 293 HONEYNAPS: COMPANY OVERVIEW
  • TABLE 294 SLEEPIMAGE: COMPANY OVERVIEW
  • TABLE 295 SLEEP RESET: COMPANY OVERVIEW
  • TABLE 296 BIGHEALTH: COMPANY OVERVIEW
  • TABLE 297 BODYMATTER, INC.: COMPANY OVERVIEW
  • TABLE 298 NEYBOX DIGITAL LTD.: COMPANY OVERVIEW
  • TABLE 299 CONSUMER SLEEP SOLUTIONS LLC: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 MARKETS & REGIONS COVERED
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 6 SUPPLY-SIDE MARKET ESTIMATION
  • FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024-2030)
  • FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 9 TOP-DOWN APPROACH
  • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • FIGURE 11 SLEEP SOFTWARE MARKET, BY TYPE, 2024 VS. 2030 (USD MILLION)
  • FIGURE 12 SLEEP SOFTWARE MARKET, BY OFFERING, 2024 VS. 2030 (USD MILLION)
  • FIGURE 13 SLEEP SOFTWARE MARKET, BY FUNCTION, 2024 VS. 2030 (USD MILLION)
  • FIGURE 14 SLEEP SOFTWARE MARKET, BY INDICATION, 2024 VS. 2030 (USD MILLION)
  • FIGURE 15 SLEEP SOFTWARE MARKET, BY DEPLOYMENT, 2024 VS. 2030 (USD MILLION)
  • FIGURE 16 SLEEP SOFTWARE MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
  • FIGURE 17 SLEEP SOFTWARE MARKET: GEOGRAPHICAL SNAPSHOT
  • FIGURE 18 AWARENESS REGARDING SLEEP-RELATED DISORDERS AND HIGH RETURNS ON INVESTMENT FOR SLEEP SOFTWARE SOLUTIONS TO DRIVE MARKET GROWTH
  • FIGURE 19 INDIVIDUAL USERS IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 20 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 21 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES THAN DEVELOPED ECONOMIES DURING FORECAST PERIOD
  • FIGURE 22 SLEEP SOFTWARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 23 HEALTHCARE SECURITY BREACHES OF 500+ RECORDS IN US, 2009-2024
  • FIGURE 24 MEDIAN HEALTHCARE DATA BREACH SIZE BY YEAR IN US, 2009-2024
  • FIGURE 25 INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES IN US, 2009-2023
  • FIGURE 26 WORLD POPULATION COVERAGE, BY TYPE OF MOBILE NETWORK, 2015-2023
  • FIGURE 27 REGIONAL POPULATION COVERAGE, BY TYPE OF MOBILE NETWORK, 2023
  • FIGURE 28 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES IN SLEEP SOFTWARE MARKET
  • FIGURE 29 SLEEP SOFTWARE MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 30 SLEEP SOFTWARE MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 31 AVERAGE SELLING PRICE OF SLEEP APPS, BY KEY PLAYER (2023)
  • FIGURE 32 SLEEP SOFTWARE MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 33 PATENT PUBLICATION TRENDS IN SLEEP SOFTWARE MARKET, 2015-2024
  • FIGURE 34 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR SLEEP SOFTWARE PATENTS (JANUARY 2015-DECEMBER 2024)
  • FIGURE 35 MAJOR PATENTS IN SLEEP SOFTWARE MARKET (JANUARY 2015-DECEMBER 2024)
  • FIGURE 36 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
  • FIGURE 37 KEY BUYING CRITERIA FOR TOP END USERS
  • FIGURE 38 RECENT FUNDING OF PLAYERS IN SLEEP SOFTWARE MARKET
  • FIGURE 39 MARKET POTENTIAL OF AI/GENERATIVE AI IN ENHANCING SLEEP SOFTWARE ACROSS INDUSTRIES
  • FIGURE 40 NORTH AMERICA: SLEEP SOFTWARE MARKET SNAPSHOT
  • FIGURE 41 ASIA PACIFIC: SLEEP SOFTWARE MARKET SNAPSHOT
  • FIGURE 42 REVENUE ANALYSIS OF KEY PLAYERS IN SLEEP SOFTWARE MARKET, 2019-2023 (USD MILLION)
  • FIGURE 43 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SLEEP SOFTWARE MARKET (2023)
  • FIGURE 44 SLEEP SOFTWARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 45 SLEEP SOFTWARE MARKET: COMPANY FOOTPRINT
  • FIGURE 46 SLEEP SOFTWARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 47 EV/EBITDA OF KEY SLEEP SOFTWARE VENDORS (2025)
  • FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND A 5-YEAR STOCK BETA OF SLEEP SOFTWARE VENDORS (2024)
  • FIGURE 49 SLEEP SOFTWARE MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS
  • FIGURE 50 RESMED: COMPANY SNAPSHOT
  • FIGURE 51 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • FIGURE 52 INSPIRE MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
  • FIGURE 53 COMPUMEDICS LIMITED: COMPANY SNAPSHOT
  • FIGURE 54 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
  • FIGURE 55 SLEEP CYCLE: COMPANY SNAPSHOT
  • FIGURE 56 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT